课题基金 / 基金详情

Molecular etiology of cervicovaginal adenosis by in utero hormone exposure

Molecular etiology of cervicovaginal adenosis by in utero hormone exposure
子宫内激素暴露导致宫颈阴道腺病的分子病因学
批准号:
8099471
负责人:
Takeshi Kurita
金额:
$30.69万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2015-04-30

项目摘要

项目成果

Takeshi Kurita的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本研究的最终目的是阐明宫颈和阴道腺病发展及其进展为腺癌的分子机制。宫颈和阴道腺病是一种先天性异常,定义为宫颈外和阴道正常鳞状(扁平)上皮中存在柱状(高)腺细胞。宫颈/阴道腺病已在宫颈/阴道透明细胞腺癌(CCAC)与子宫内暴露于合成雌激素己烯雌酚(DES)相关的背景下进行了研究。子宫内暴露于DES的妇女患CCAC的风险增加,这被认为是由先前存在的腺病病变引起的。尽管在1971年禁止孕妇使用DES后发病率显著下降,但在没有DES暴露史的妇女中仍有宫颈/阴道腺病和CCAC的报道,这表明环境中还有其他因素导致了这些情况。通过小鼠模型,我们之前已经证明,发育暴露于DES通过破坏p63转录因子的表达诱导宫颈/阴道腺病,p63转录因子对鳞状上皮的发育至关重要。为了阐明宫颈/阴道腺病的发病机制,我们建议研究诱导p63在发育中的宫颈/阴道上皮表达的信号机制,以及发育中暴露于雌激素和甲状腺激素如何破坏这一信号。首先,我们将利用小鼠模型和细胞系报告基因分析系统研究p63启动子是如何被发育调控的。此外,我们还建议研究腺病向腺癌的进展。宫颈和阴道CCACs通常对人乳头瘤病毒(HPV)感染呈阴性,其病因尚不清楚。最近,在子宫颈CCACs中,PIK3Ca或PTEN基因突变导致PI3K(磷脂酰肌醇-3激酶)信号不受控制的激活的高发生率已被报道。因此,我们将利用p63和Pten肿瘤抑制因子双敲除小鼠模型,探讨PI3K信号不受控制的激活是否会将腺病转化为腺癌。从这项研究中获得的知识将帮助我们识别存在于我们环境中的宫颈/阴道腺病的潜在危险因素。此外,通过研究hpv阴性宫颈/阴道腺癌的分子病因学,可能会导致早期发现和发现一种新的和改进的治疗方法。
英文摘要
DESCRIPTION (provided by applicant): The ultimate goal of this study is to elucidate the molecular mechanisms of cervical and vaginal adenosis development and its progression to adenocarcinoma. Cervical and vaginal adenosis is a congenital anomaly defined as the presence of columnar (tall) glandular cells in normally squamous (flat) epithelium of ectocervix and vagina. Cervical/vaginal adenosis has been studied in the context of cervical/vaginal clear cell adenocaricinoma (CCAC) associated with in utero exposure to a synthetic estrogen diethylstilbestrol (DES). Women exposed to DES in utero are at increased risk of developing CCAC, which is believed to arise from preexisting adenosis lesions. Although incidences have declined significantly after DES use for pregnant women was banned in 1971, cervical/vagina adenosis and CCAC are still reported in women without history of DES exposure, suggesting that there are other factors that contribute to these conditions in the environment. Using a mouse model, we have previously demonstrated that developmental exposure to DES induces cervical/vaginal adenosis by disrupting expression of p63 transcription factor, which is essential for development of squamous epithelia. To elucidate the pathogenesis of cervical/vaginal adenosis, we propose to study signaling mechanism that induces p63 expression in developing cervical/vaginal epithelium, and how developmental exposure to estrogen and thyroid hormone disrupts this signaling. Primarily, we will study how p63 promoter is developmentally regulated using mouse model and reporter assay system with cell line. In addition, we also propose to study progression of adenosis to adenocarcinoma. The cervical and vaginal CCACs are generally negative for human papilloma virus (HPV) infection, and their etiology is not understood. Recently, high incidence of mutations in PIK3Ca or PTEN gene resulting in uncontrolled-activation of PI3K (phosphatidylinositol-3 kinase) signaling has been reported in CCACs of cervix. Therefore, we will explore whether uncontrolled-activation of PI3K signaling transforms adenosis into adenocarcinoma using double knockout mouse model for p63 and Pten tumor suppressor. The knowledge obtained from this study will help us identify potential risk factors that exist in our environment for cervical/vaginal adenosis. In addition, by studying molecular etiology of HPV-negative cervical/vaginal adenocarcinoma, it may lead to early detection and discovery of a new and improved treatment for this disease. PUBLIC HEALTH RELEVANCE: Although adenocarcinomas of ectocervix and vagina are believed to arise from preexisting benign adenosis lesions, its etiology is unknown. This project will identify the risk factor (e.g. environmental chemicals) for adenosis and adenocarcinoma of ectocervix and vagina by elucidating the molecular pathogenesis of these conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Xenograft Study on Growth-Control of Human Uterine Leiomyomata
  • 批准号:
    8839966
  • 项目类别:
  • 资助金额:
    $22.05万
  • 财政年份:
    2014
  • 负责人:
    Takeshi Kurita
  • 依托单位:
Molecular Etiology of Cervicovaginal Adenosis by in Utero Hormone Exposure
  • 批准号:
    8840386
  • 项目类别:
  • 资助金额:
    $29.5万
  • 财政年份:
    2014
  • 负责人:
    Takeshi Kurita
  • 依托单位:
Core B: Tissue Procurement and Cell Culture Core
Xenograft Study on Growth-Control of Human Uterine Leiomyomata
海外基金